Valentina S. Orlova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Valentina S. Orlova has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Dmitry D. Zhdanov
Institute of Biomedical Chemistry, Moscow, Russia
12 shared publications N. N. Sokolov
Orekhovich Institute of Biomedical Chemistry
8 shared publicationsS. S. Aleksandrova
Orekhovich Institute of Biomedical Chemistry
8 shared publications- Vadim Sergeevich Pokrovskii
N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 23, 115522 Moscow, Russia
8 shared publications M. V. Pokrovskaya
Orekhovich Institute of Biomedical Chemistry
7 shared publicationsD. A. Vasina
Peoples Friendship University of Russia
5 shared publications
Latest Publications
- 6 March 2026
- Published by ECO-Vector LLC (Publications) in Epidemiology and Infectious Diseases
- Vol. 31 (1) , 51-63
Equal yet different: a comparative characterization of Ruthenibacterium lactatiformans and Faecalibacterium prausnitzii
The gut microbiota plays a key role in maintaining human homeostasis. Of particular interest are 2 bacterial species of the family Oscillospiraceae: the well-studied Faecalibacterium prausnitzii, with proven anti-inflammatory properties, and the recently described Ruthenibacterium lactatiformans, whose functional potential remains insufficiently investigated. Despite their phylogenetic proximity, these species differ substantially in metabolic properties, associations with pathological conditions, and probiotic potential. The work aimed to conduct a comparative analysis of the characteristics of F. prausnitzii and R. lactatiformans and their interactions with the host, as well as to summarize data on possible mechanisms underlying their influence on the development of a wide range of diseases, including inflammatory bowel diseases, cardiovascular, metabolic, neurologic, and oncologic diseases. Studies demonstrate that reduced abundance of F. prausnitzii serves as a reliable biomarker of dysbiosis and is associated with chronic inflammatory, autoimmune, and metabolic diseases. The protective role of this bacterium is primarily related to butyrate production and immunomodulation. In contrast to F. prausnitzii, associations of R. lactatiformans with pathological conditions are inconsistent. Increased abundance of this species correlates with both pathological states (stroke, active multiple sclerosis) and periods of clinical remission in certain diseases. At the same time, in experimental models, R. lactatiformans demonstrates protective, particularly metabolic, properties. The decrease in F. prausnitzii abundance under pathological conditions is likely explained by its sensitivity to environmental changes such as tissue acidosis and oxidative stress. In contrast, R. lactatiformans, owing to greater metabolic plasticity (ability to produce lactate and acetate) and relative aerotolerance, is capable of adapting to these unfavorable conditions. In conclusion, we support the hypothesis that the observed changes may reflect a dynamic dysbiotic shift and potential synergism rather than competition: R. lactatiformans, acting as an adaptive substrate supplier, may contribute to restoration of conditions favorable for subsequent colonization by butyrate-producing bacteria such as F. prausnitzii. This opens new perspectives for the development of probiotic strategies based on synergistic bacterial consortia.
- 6 March 2026
- Published by ECO-Vector LLC (Publications) in Epidemiology and Infectious Diseases
- Vol. 31 (1) , 51-63
Equal yet different: a comparative characterization of Ruthenibacterium lactatiformans and Faecalibacterium prausnitzii
The gut microbiota plays a key role in maintaining human homeostasis. Of particular interest are 2 bacterial species of the family Oscillospiraceae: the well-studied Faecalibacterium prausnitzii, with proven anti-inflammatory properties, and the recently described Ruthenibacterium lactatiformans, whose functional potential remains insufficiently investigated. Despite their phylogenetic proximity, these species differ substantially in metabolic properties, associations with pathological conditions, and probiotic potential. The work aimed to conduct a comparative analysis of the characteristics of F. prausnitzii and R. lactatiformans and their interactions with the host, as well as to summarize data on possible mechanisms underlying their influence on the development of a wide range of diseases, including inflammatory bowel diseases, cardiovascular, metabolic, neurologic, and oncologic diseases. Studies demonstrate that reduced abundance of F. prausnitzii serves as a reliable biomarker of dysbiosis and is associated with chronic inflammatory, autoimmune, and metabolic diseases. The protective role of this bacterium is primarily related to butyrate production and immunomodulation. In contrast to F. prausnitzii, associations of R. lactatiformans with pathological conditions are inconsistent. Increased abundance of this species correlates with both pathological states (stroke, active multiple sclerosis) and periods of clinical remission in certain diseases. At the same time, in experimental models, R. lactatiformans demonstrates protective, particularly metabolic, properties. The decrease in F. prausnitzii abundance under pathological conditions is likely explained by its sensitivity to environmental changes such as tissue acidosis and oxidative stress. In contrast, R. lactatiformans, owing to greater metabolic plasticity (ability to produce lactate and acetate) and relative aerotolerance, is capable of adapting to these unfavorable conditions. In conclusion, we support the hypothesis that the observed changes may reflect a dynamic dysbiotic shift and potential synergism rather than competition: R. lactatiformans, acting as an adaptive substrate supplier, may contribute to restoration of conditions favorable for subsequent colonization by butyrate-producing bacteria such as F. prausnitzii. This opens new perspectives for the development of probiotic strategies based on synergistic bacterial consortia.
- Open Access
- 15 January 2019
- Published by ECO-Vector LLC in Ekologiya cheloveka (Human Ecology)
- Vol. 26 (1) , 34-39
EXOGENOUS FACTORS OF PARKINSON'S DISEASE DEVELOPMENT
Parkinson disease (PD) is a chronic progressive neurodegenerative multifactorial disease characterized by selective loss of dopaminergic neurons in substantia nigra pars compacta. Potential risk factors include exposure to environmental toxic substances, aging processes and genetic mutations. 5-15% of all the cases are genetically determined PD. In this regard, the role of environmental factors in the development of the PD neurodegenerative process becomes particularly important. However, in most cases, the interaction of environmental and genetic factors (gene-environment interaction), apparently, appears to be the cause of PD development. At the cellular level, the pathogenetic mechanisms of the disease are associated with a violation of alpha-synuclein conformation and the formation of Lewy bodies, the development of oxidative stress, neuroinflammation, mitochondrial and protease dysfunction. This review examines the molecular mechanisms of toxic effects of various environmental pollutants that can lead neurodegenerative process and PD development: pesticides, metals, solvents, polychlorinated biphenyls and nanoparticles. The study of complex pathophysiological interactions between potential neurotoxins determining the risk of dopaminergic neurons damage and preventive neuroprotectors is one of the most perspective areas in development of PD treatment.
- 15 January 2019
- Published by ECO-Vector LLC in Ekologiya cheloveka (Human Ecology)
- Vol. 26 (1) , 34-39
Open AccessEXOGENOUS FACTORS OF PARKINSON'S DISEASE DEVELOPMENT
Parkinson disease (PD) is a chronic progressive neurodegenerative multifactorial disease characterized by selective loss of dopaminergic neurons in substantia nigra pars compacta. Potential risk factors include exposure to environmental toxic substances, aging processes and genetic mutations. 5-15% of all the cases are genetically determined PD. In this regard, the role of environmental factors in the development of the PD neurodegenerative process becomes particularly important. However, in most cases, the interaction of environmental and genetic factors (gene-environment interaction), apparently, appears to be the cause of PD development. At the cellular level, the pathogenetic mechanisms of the disease are associated with a violation of alpha-synuclein conformation and the formation of Lewy bodies, the development of oxidative stress, neuroinflammation, mitochondrial and protease dysfunction. This review examines the molecular mechanisms of toxic effects of various environmental pollutants that can lead neurodegenerative process and PD development: pesticides, metals, solvents, polychlorinated biphenyls and nanoparticles. The study of complex pathophysiological interactions between potential neurotoxins determining the risk of dopaminergic neurons damage and preventive neuroprotectors is one of the most perspective areas in development of PD treatment.
- 1 September 2018
- Published by Elsevier in Molecular Immunology
- Vol. 101, 229-244
Contact-independent suppressive activity of regulatory T cells is associated with telomerase inhibition, telomere shortening and target lymphocyte apoptosis
- 1 September 2018
- Published by Elsevier in Molecular Immunology
- Vol. 101, 229-244
Contact-independent suppressive activity of regulatory T cells is associated with telomerase inhibition, telomere shortening and target lymphocyte apoptosis
- 1 June 2018
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 95, 254-259
Neuroprotective effect of the carnosine – α-lipoic acid nanomicellar complex in a model of early-stage Parkinson's disease
- 1 June 2018
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 95, 254-259
Neuroprotective effect of the carnosine – α-lipoic acid nanomicellar complex in a model of early-stage Parkinson's disease
- 1 May 2018
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 12 (3) , 217-230
Induction of Telomerase Catalytic Subunit Alternative Splicing by Apoptotic Endonuclease G in Mouse and Rat Lymphocytes
It is known that apoptotic endonuclease G (EndoG) induces alternative splicing (AS) of telomerase catalytic subunit TERT (telomerase reverse transcriptase) mRNA and inhibits telomerase activity in...
- 1 May 2018
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 12 (3) , 217-230
Induction of Telomerase Catalytic Subunit Alternative Splicing by Apoptotic Endonuclease G in Mouse and Rat Lymphocytes
It is known that apoptotic endonuclease G (EndoG) induces alternative splicing (AS) of telomerase catalytic subunit TERT (telomerase reverse transcriptase) mRNA and inhibits telomerase activity in...
- 1 April 2018
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
- Vol. 12 (2) , 119-129
Induction of Apoptotic Endonuclease EndoG with DNA-Damaging Agents Initiates Alternative Splicing of Telomerase Catalytic Subunit hTERT and Inhibition of Telomerase Activity hTERT in Human CD4+ and CD8+ Т Lymphocytes
Activity of the telomerase catalytic subunit hTERT (human Telomerase Reverse Transcriptase) can be regulated by alternative splicing of its mRNA. At the present time, the exact mechanism of hTERT...
- 1 April 2018
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
- Vol. 12 (2) , 119-129
Induction of Apoptotic Endonuclease EndoG with DNA-Damaging Agents Initiates Alternative Splicing of Telomerase Catalytic Subunit hTERT and Inhibition of Telomerase Activity hTERT in Human CD4+ and CD8+ Т Lymphocytes
Activity of the telomerase catalytic subunit hTERT (human Telomerase Reverse Transcriptase) can be regulated by alternative splicing of its mRNA. At the present time, the exact mechanism of hTERT...
- 1 January 2018
- Published by Pleiades Publishing Ltd in Citologiâ
- Vol. 60 (2) , 104-115
INDUCTION OF ALTERNATIVE SPLICING OF TELOMERASE CATALYTIC SUBUNIT BY APOPTOTIC ENDONUCLEASE EndoG IN MURINE LIMPHOCYTES
- 1 January 2018
- Published by Pleiades Publishing Ltd in Citologiâ
- Vol. 60 (2) , 104-115
INDUCTION OF ALTERNATIVE SPLICING OF TELOMERASE CATALYTIC SUBUNIT BY APOPTOTIC ENDONUCLEASE EndoG IN MURINE LIMPHOCYTES